Advertisement The Case for NMT in Life Sciences - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More


The Case for NMT in Life Sciences

As companies across industries expand their service offerings and geographic reach, machine translation (MT) has quickly become the ‘go-to’ resource for translating a wide array of material.

RWS’s 2022 eBook, The Case for NMT in Life Sciences, walks you through the benefits of neural machine translation (NMT) as it pertains to life sciences. We’ll discuss how NMT is closing the gap between expectation and reality, when and where NMT is best suited, how NMT can positively affect the translation process, and the future of NMT as we see it.